ResearcherTianjin Medical University Cancer Institute and HospitalNo recent work listed
Haotian Wang
Matched on ORCID iD 0000-0002-3527-8171; OpenAlex author ID A5100383997. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 15
2019: 1 paper · 2020: none · 2021: none · 2022: 1 paper · 2023: 1 paper
Papers 3
- Retraction notice to "HIF-1α mediates tumor-nerve interactions through the up-regulation of GM-CSF in pancreatic ductal adenocarcinoma" [Cancer Lett. 453 (2019… Co-author DOI 10.1016/j.canlet.2023.216059↗
- ESE3/EHF, a promising target of rosiglitazone, suppresses pancreatic cancer stemness by downregulating CXCR4. Co-author DOI 10.1136/gutjnl-2020-321952↗
- RETRACTED: HIF-1α mediates tumor-nerve interactions through the up-regulation of GM-CSF in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.canlet.2019.03.036↗
Closest collaborators
The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Xiuchao Wang · 3 shared papers, 2019–2023 · strength 0.37
- Paper Retraction notice to "HIF-1α mediates tumor-nerve interactions through the up-regulation of GM-CSF in pancreatic ductal… DOI 10.1016/j.canlet.2023.216059↗
- Paper ESE3/EHF, a promising target of rosiglitazone, suppresses pancreatic cancer stemness by downregulating CXCR4. DOI 10.1136/gutjnl-2020-321952↗
- Paper RETRACTED: HIF-1α mediates tumor-nerve interactions through the up-regulation of GM-CSF in pancreatic ductal adenocarci… DOI 10.1016/j.canlet.2019.03.036↗
- Tiansuo Zhao · 3 shared papers, 2019–2023 · strength 0.37
- Paper Retraction notice to "HIF-1α mediates tumor-nerve interactions through the up-regulation of GM-CSF in pancreatic ductal… DOI 10.1016/j.canlet.2023.216059↗
- Paper ESE3/EHF, a promising target of rosiglitazone, suppresses pancreatic cancer stemness by downregulating CXCR4. DOI 10.1136/gutjnl-2020-321952↗
- Paper RETRACTED: HIF-1α mediates tumor-nerve interactions through the up-regulation of GM-CSF in pancreatic ductal adenocarci… DOI 10.1016/j.canlet.2019.03.036↗
- Jihui Hao · 3 shared papers, 2019–2023 · strength 0.37
- Paper Retraction notice to "HIF-1α mediates tumor-nerve interactions through the up-regulation of GM-CSF in pancreatic ductal… DOI 10.1016/j.canlet.2023.216059↗
- Paper ESE3/EHF, a promising target of rosiglitazone, suppresses pancreatic cancer stemness by downregulating CXCR4. DOI 10.1136/gutjnl-2020-321952↗
- Paper RETRACTED: HIF-1α mediates tumor-nerve interactions through the up-regulation of GM-CSF in pancreatic ductal adenocarci… DOI 10.1016/j.canlet.2019.03.036↗
- Liangliang Wu · 2 shared papers, 2019–2023 · strength 0.24
- Paper Retraction notice to "HIF-1α mediates tumor-nerve interactions through the up-regulation of GM-CSF in pancreatic ductal… DOI 10.1016/j.canlet.2023.216059↗
- Paper RETRACTED: HIF-1α mediates tumor-nerve interactions through the up-regulation of GM-CSF in pancreatic ductal adenocarci… DOI 10.1016/j.canlet.2019.03.036↗
- Mingxiao Lang · 2 shared papers, 2019–2023 · strength 0.24
- Paper Retraction notice to "HIF-1α mediates tumor-nerve interactions through the up-regulation of GM-CSF in pancreatic ductal… DOI 10.1016/j.canlet.2023.216059↗
- Paper RETRACTED: HIF-1α mediates tumor-nerve interactions through the up-regulation of GM-CSF in pancreatic ductal adenocarci… DOI 10.1016/j.canlet.2019.03.036↗
- Shengyu Yang · 1 shared paper, 2022 · strength 0.13
- Chongbiao Huang · 1 shared paper, 2022 · strength 0.13
- Song Gao · 1 shared paper, 2022 · strength 0.13
- Shuai Yuan · 1 shared paper, 2022 · strength 0.13
- Wenna Jiang · 1 shared paper, 2022 · strength 0.13
- Yongjie Xie · 1 shared paper, 2022 · strength 0.13
- Tianxing Zhou · 1 shared paper, 2022 · strength 0.13
- Jing Liu · 1 shared paper, 2022 · strength 0.13
- Zengxun Li · 1 shared paper, 2019 · strength 0.08
- He Ren · 1 shared paper, 2019 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.